Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
517
datasets available to search
ShareScore release 0.9.0
Dataset results
517 results for “Neoadjuvant treatment;”
Sintilimab in Combination With Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal Cancer
ClinicalTrials.gov study NCT03946969. IPD Sharing: NO. Countries: 1. Publications: 1.
Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer
ClinicalTrials.gov study NCT00600210. IPD Sharing: Not stated. Countries: 1. Publications: 48.
Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant Treatment
ClinicalTrials.gov study NCT05132790. IPD Sharing: YES. Countries: 1. Publications: 2.
Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC
ClinicalTrials.gov study NCT05213312. IPD Sharing: Not stated. Countries: 1. Publications: 49.
Analysis of the Effectiveness of Neoadjuvant Chemotherapy in the Treatment of Colon Cancer Locally Advanced (ELECLA)
ClinicalTrials.gov study NCT04188158. IPD Sharing: NO. Countries: 1. Publications: 1.
Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal Melanoma
ClinicalTrials.gov study NCT03313206. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast Cancer
ClinicalTrials.gov study NCT00813956. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients
ClinicalTrials.gov study NCT03916627. IPD Sharing: YES. Countries: 1. Publications: 1.
Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer
ClinicalTrials.gov study NCT04309136. IPD Sharing: NO. Countries: 1. Publications: 1.
Neoadjuvant Treatment for Advanced Rectal Carcinoma
ClinicalTrials.gov study NCT02551237. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PD1 Antibody (Toripalimab), GEMOX and Lenvatinib Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
ClinicalTrials.gov study NCT04506281. IPD Sharing: NO. Countries: 1. Publications: 5.
Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone
ClinicalTrials.gov study NCT02806258. IPD Sharing: YES. Countries: 1. Publications: 1.
Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment in Participants With Breast Cancer
ClinicalTrials.gov study NCT03329937. IPD Sharing: YES. Countries: 0. Publications: 1.
Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRI
ClinicalTrials.gov study NCT05511116. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Gr
ClinicalTrials.gov study NCT03725059. IPD Sharing: YES. Countries: 24. Publications: 2.
Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Hilar Cholangiocarcinoma. A Prospective Multicenter Study.
ClinicalTrials.gov study NCT04378023. IPD Sharing: NO. Countries: 1. Publications: 5.
Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid Cancers
ClinicalTrials.gov study NCT04180007. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT
ClinicalTrials.gov study NCT05225116. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Efficacy Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy as Neoadjuvant Treatment for Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-173/KEYNOTE-173)
ClinicalTrials.gov study NCT02622074. IPD Sharing: YES. Countries: 0. Publications: 3.
Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.
ClinicalTrials.gov study NCT06940388. IPD Sharing: UNDECIDED. Countries: 2. Publications: 18.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.